Sleep

• 

  Publication Venue For

  • Problematic technology use and sleep quality in young adulthood: novel insights from a nationally representative twin study..  zsad038. 2023
  • Is insomnia associated with deficits in neuropsychological functioning? Evidence from a population-based study..  38:623-631. 2015
  • Mental health antecedents of early midlife insomnia: evidence from a four-decade longitudinal study..  37:1767-1775. 2014
  • Mental Health Antecedents of Early Midlife Insomnia: Evidence from a Four-Decade Longitudinal Study. 2014
  • Telomere length is associated with sleep duration but not sleep quality in adults with human immunodeficiency virus.  37:157-166. 2014
  • The Association of Sleep Duration, Mental Health, and Health Risk Behaviors among U.S. Afghanistan/Iraq Era Veterans..  36:1019-1025. 2013
  • Sleep deprivation alters effort discounting but not delay discounting of monetary rewards..  36:899-904. 2013
  • The longitudinal course of insomnia symptoms: inequalities by sex and occupational class among two different age cohorts followed for 20 years in the west of Scotland..  35:815-823. 2012
  • Maternal insomnia and children's family socialization environments..  35:579-582. 2012
  • Contribution of cancer symptoms, dysfunctional sleep related thoughts, and sleep inhibitory behaviors to the insomnia process in breast cancer survivors: a daily process analysis..  33:1501-1509. 2010
  • Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia..  33:1553-1561. 2010
  • In vivo evidence of the specificity of effects of GABA(A) receptor modulating medications..  33:859-860. 2010
  • Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia..  33:669-677. 2010
  • Sociodemographic and health correlates of sleep quality and duration among very old Chinese..  33:601-610. 2010
  • A 12-week, randomized, double-blind, placebo-controlled study evaluating the effect of eszopiclone 2 mg on sleep/wake function in older adults with primary and comorbid insomnia..  33:225-234. 2010
  • Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial..  32:499-510. 2009
  • Psychomotor performance deficits and their relation to prior nights' sleep among individuals with primary insomnia..  31:599-607. 2008
  • Long-term efficacy and safety of zolpidem extended-release 12.5 mg, administered 3 to 7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study..  31:79-90. 2008
  • Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations..  30:959-968. 2007
  • Sleep deprivation elevates expectation of gains and attenuates response to losses following risky decisions..  30:603-609. 2007
  • Dose-response effects of cognitive-behavioral insomnia therapy: a randomized clinical trial..  30:203-212. 2007
  • Family conflict in childhood: a predictor of later insomnia..  29:1063-1067. 2006
  • Defining insomnia: quantitative criteria for insomnia severity and frequency..  29:479-485. 2006
  • Individual Variation in Rapid Eye Movement Sleep Is Associated With Pain Perception in Healthy Women: Preliminary Data.  28:809-812. 2005
  • Reduced extracellular dopamine and increased responsiveness to novelty: neurochemical and behavioral sequelae of intermittent hypoxia..  28:169-176. 2005
  • The possibility of preventing functional impairment due to sleep loss by pharmacologically enhancing sleep..  28:16-17. 2005
  • Sleep-disordered breathing is not associated with the presence of retinal microvascular abnormalities: the Sleep Heart Health Study..  27:467-473. 2004
  • The Sustained 6-Month Efficacy of Eszopiclone in the Treatment of Chronic Insomnia.  27:346-347. 2004
  • Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia..  26:793-799. 2003
  • A primary care "friendly" cognitive behavioral insomnia therapy..  26:177-182. 2003
  • The effects of psychotherapy, nefazodone, and their combination on subjective assessment of disturbed sleep in chronic depression..  26:130-136. 2003
  • Excessive daytime somnolence and increased rapid eye movement pressure in myotonic dystrophy..  25:662-665. 2002
  • NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes..  25:630-640. 2002
  • A within-subject study of the relationship of non-REM EEG spectral amplitude and the agreement between subjective and objective assessments of sleep time.  25:A33-A34. 2002
  • Behavioral insomnia therapy for patients with fibromyalgia.  25:A384-A384. 2002
  • The best of both: Brief hypnotic use to enhance behavioral insomnia therapy.  25:A360-A361. 2002
  • Three-month non-nightly use of zolpidem for the treatment of primary insomnia.  25:A68-A68. 2002
  • Does cognitive-behavioral insomnia therapy alter dysfunctional beliefs about sleep?.  24:591-599. 2001
  • A pilot study of the sleep EEG power spectral effects of behavioral therapy in primary insomniacs.  24:A62-A62. 2001
  • Temporal characteristics of delta activity during NREM sleep in depressed outpatients and healthy adults: group and sex effects..  23:607-617. 2000
  • Incidence and remission of insomnia among elderly adults in a biracial cohort..  22 Suppl 2:S373-S378. 1999
  • Incidence and remission of insomnia among elderly adults: an epidemiologic study of 6,800 persons over three years..  22 Suppl 2:S366-S372. 1999
  • Do our methods lead to insomniacs' madness?: Daytime testing after laboratory and home-based polysomnographic studies..  20:1127-1134. 1997
  • Sleep in the laboratory and sleep at home: comparisons of older insomniacs and normal sleepers..  20:1119-1126. 1997
  • Computer classification of state in healthy preterm neonates..  20:132-141. 1997
  • Comparison of cognitive-behavioral therapy and clonazepam for treating periodic limb movement disorder..  19:442-444. 1996
  • The empirical identification of insomnia subtypes: a cluster analytic approach..  19:398-411. 1996
  • The effect of hypoxia on baroreflexes and pressor sensitivity in sleep apnea and hypertension..  18:859-865. 1995
  • Postnatal adaptation of brain function in full-term neonates as assessed by EEG sleep analyses..  18:531-535. 1995
  • Sleep complaints among elderly persons: an epidemiologic study of three communities..  18:425-432. 1995
  • Comparisons of EEG sleep state-specific spectral values between healthy full-term and preterm infants at comparable postconceptional ages..  17:47-51. 1994
  • Use of in vivo desensitization to treat a patient's claustrophobic response to nasal CPAP..  16:678-680. 1993
  • Aerobic fitness, acute exercise and sleep in older men..  16:351-359. 1993
  • Periodic limb movement variability in older DIMS patients across consecutive nights of home monitoring..  15:156-161. 1992
  • Acute deprivation of the terminal four hours of sleep does not increase delta (0-3-Hz) electroencephalograms: a replication..  14:320-324. 1991
  • Nothing new about insomnia (I: Reply).  13:191-192. 1990
  • Polysomnographic assessment of DIMS: empirical evaluation of its diagnostic value..  12:315-322. 1989
  • Ambulatory sleep monitoring with the Oxford-Medilog 9000: technical acceptability, patient acceptance, and clinical indications..  10:606-607. 1987
  • ASSOCIATIONS BETWEEN SLEEP PROBLEMS AND ADHD SYMPTOMS IN EARLY CHILDHOOD: A LONGITUDINAL, PRIMARY-CARE BASED STUDY 2022
  • SLEEP AND NEUROCOGNITION IN ADOLESCENTS WITH ADHD: A POLYSOMNOGRAPHIC STUDY 2022
  • DIFFERENTIAL IMPACT OF OVERNIGHT DELTA POWER DYNAMICS ON NEUROCOGNITION AMONG ADOLESCENTS WITH ADHD VERSUS HEALTHY CONTROLS 2021
  • DO THE SUBJECTIVE EFFECTS OF HYPNOTIC MEDICATIONS RESULT IN UNBLINDING OF TREATMENT ASSIGNMENT IN HYPNOTIC RANDOMIZED CLINICAL TRIALS? 2020
  • FACTORS ASSOCIATED WITH THE CONTINUOUS USE OF PSYCHOTROPIC TREATMENTS FOR NARCOLEPSY 2020
  • SLEEP ASSOCIATED WITH EXECUTIVE FUNCTIONING AMONG ADOLESCENTS ACROSS THE ADHD CONTINUUM 2020
  • 0403 Tele-Self CBTI: Provider Supported Self-Management Cognitive Behavioral Therapy for Insomnia 2018
  • 0497 Physical Traits are More Predictive than Symptoms of Moderate-to-Severe Sleep Apnea in Men 2018
  • 0639 A Preliminary Report from the “REST-IT” Study: Self-reported Eveningness and Actigraphic Delayed Sleep Timing Correlate with Suicidal Ideation in Individuals with Depression and Insomnia 2018
  • 0762 Sleeping at Home: Feasibility and Tolerability of Ambulatory Polysomnography for Use with Adolescents with Attention-Deficit/Hyperactivity Disorder 2018
  • 0335 DOES OBJECTIVE SLEEP DURATION MODERATE TREATMENT RESPONSE IN PATIENT WITH COMORBID DEPRESSION AND INSOMNIA? A REPORT FROM THE TRIAD STUDY 2017
  • 0341 SEQUENTIAL THERAPIES FOR COMORBID AND PRIMARY INSOMNIA: A RANDOMIZED CONTROLLED TRIAL 2017
  • 0395 CLINICAL PRACTICE GUIDELINE FOR THE PHARMACOLOGIC TREATMENT OF CHRONIC INSOMNIA IN ADULTS: AN AMERICAN ACADEMY OF SLEEP MEDICINE CLINICAL PRACTICE GUIDELINE 2017
  • Dose response effects of behavioral insomnia therapy: Final report 2004
  • Mediators of symptomatic improvements derived from behavioral insomnia therapy 2004
  • Use of sodium oxybate in veterans with narcolepsy 2004
  • Behavioral insomnia therapy for patients with fibromyalgia: An update 2003
  • CPAP compliance in apnea patients diagnosed via attended (split-night) versus unattended polysomnography 2003
  • Dose response effects of behavioral insomnia therapy: Clinical trial update 2003
  • Efficacy and tolerability of four doses of indiplon (NBI-34060) modified-release in elderly patients with sleep maintenance insomnia 2003
  • Measurement of sleep in young insomniacs: A multi-trait, multi-method approach 2003
  • Prevalence of restless legs symptoms in an elderly American veteran cohort 2003
  • Should women with obstructive sleep apnea syndrome be screened for hypothyroidism? 2003
  • Transcranial magnetic stimulation in non-sleep-deprived and sleep-deprived patients 2003
  • Changes in Beck depression inventory (BDI) symptoms after continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) 2002
  • Comparison of home and laboratory actigraphy in young adults with and without primary insomnia 2002
  • Does cognitive-behavioral insomnia therapy really alter dysfunctional beliefs about sleep? 2001
  • Dose response effects of behavioral insomnia therapy: How many sessions are enough? 2001
  • Excessive daytime somnolence and increased REM pressure in myotonic dystrophy 2001
  • Evaluation and comparison of two autotitrating CPAP machines 2001